Blood Tests Before and After Starting Statins
Before prescribing statins your doctor should run specific baseline tests — and monitor them periodically afterward. Here is exactly what to expect, what each test is checking for, and what values prompt clinical attention.
Upload your blood test PDF and get a free scored health breakdown.
Get My Score →Baseline Tests Before Starting a Statin
| Test | Purpose |
|---|---|
| Full lipid panel (LDL, HDL, triglycerides) | Establish baseline to measure treatment response |
| ALT (liver enzyme) | Baseline liver status — statins rarely cause liver injury but a baseline is needed |
| CK (creatine kinase) | Baseline muscle enzyme — needed to evaluate any subsequent muscle symptoms |
| HbA1c or fasting glucose | Statins modestly increase diabetes risk (~10–12%) — important to assess before and during treatment |
| TSH | Hypothyroidism raises LDL and can cause statin-related myopathy — must be excluded before starting statins |
| eGFR and creatinine | Kidney function affects statin dose choice |
Hypothyroidism Must Be Excluded Before Statins
Undiagnosed hypothyroidism is a key contraindication to starting statins — it both raises LDL (treating the thyroid often normalises cholesterol without statins) and significantly increases the risk of statin-induced myopathy. TSH should be checked before every new statin prescription. If hypothyroidism is found, treat it first and recheck the lipid panel 2–3 months later.
Tests to Run Before Starting Any Statin
Monitoring After Starting a Statin
Lipid panel: recheck 4–8 weeks after starting or changing dose to assess LDL response. Once the target is met and the dose is stable, annually is sufficient. ALT: routine monitoring is no longer recommended in US guidelines unless there are symptoms suggesting liver problems — the risk of clinically significant statin-induced liver injury is approximately 1 in 100,000. CK: routine monitoring is not recommended; check only if a patient reports muscle pain, weakness, or dark urine. CK above 10x the upper limit of normal, particularly with symptoms, indicates myopathy — the statin should be stopped.
When to Retest After Starting a Statin
Statin-Induced Myopathy: What to Watch For
Muscle symptoms (myalgia) occur in 5–10% of statin users in clinical practice, though rates in controlled trials are lower. True myopathy with CK elevation occurs in less than 0.1%. Rhabdomyolysis (severe muscle breakdown with kidney damage) is rare (approximately 1 in 10,000 users annually). Risk is higher with higher doses, interacting medications (particularly CYP3A4 inhibitors like certain antibiotics, antifungals, and grapefruit), hypothyroidism, and kidney impairment. If you develop muscle pain on a statin, get a CK level before stopping — most people with symptoms have normal CK and symptoms can often be managed by switching to a different statin.
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Reference ranges, supplement dosages, and nutritional information mentioned are general educational guidance from published research—not personalised recommendations. Do not use this content to self-diagnose or self-treat any condition. Always consult a qualified healthcare provider before making any changes to your health regimen, medications, or supplements.
See exactly where your results stand
Upload your blood test PDF and get a free A–F score across all 6 health domains in seconds.
Analyze My Blood Test →